Evaluation of the adjunctive use of Er:YAG laser or erythritol powder air-polishing in the treatment of peri-implant mucositis: A randomized clinical trial

被引:4
|
作者
Clementini, Marco [1 ,2 ,4 ]
Fabrizi, Simone [1 ]
Discepoli, Nicola [3 ]
Minoli, Margherita [1 ]
De Sanctis, Massimo [1 ]
机构
[1] Univ Vita Salute San Raffaele, Dept Periodontol, Milan, Italy
[2] UniCamillus St Camillus Int Univ Hlth Sci, Rome, Italy
[3] Univ Siena, Dept Med Biotechnol, Unit Periodont, Siena, Italy
[4] CSO Acad, Rome, Italy
关键词
Er:YAG laser; erythritol powder air-polishing; non-surgical treatment; peri-implant mucositis; submarginal instrumentation; NONSURGICAL TREATMENT; KERATINIZED MUCOSA; CONSENSUS REPORT; EFFICACY; DEVICE;
D O I
10.1111/clr.14167
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
AimTo assess the efficacy of Er:YAG laser (ERL) and erythritol powder air-polishing (AP) in addition to the submarginal instrumentation in the non-surgical treatment of peri-implant mucositis (PM).Materials and MethodsPatients with at least one implant diagnosed with PM were included in the present 6-month randomized clinical trial (RCT). Implants were randomly assigned to one of the three treatment groups after submarginal instrumentation: AP (test 1 group), ERL (test 2 group) or no adjunctive methods (control group). The primary and secondary outcomes were, respectively, bleeding on probing (BoP) reduction and, complete disease resolution (total absence of BoP) and probing pocket depth (PPD) changes. The patient and the implant were considered the statistical unit. A multivariate logistic regression analysis was performed.ResultsA total of 75 patients were enrolled in the study. At each time point, significant BoP and PPD reductions were observed within each group. Intergroup analysis did not show statistically significant differences. Complete disease resolution ranged between 29% and 31%. The logistic regression showed that supramucosal restoration margin, PPD < 4 mm and vestibular keratinized mucosa (KM) significantly influenced the probability to obtain treatment success.ConclusionThe adjunctive use of AP and ERL in PM non-surgical therapy does not seem to provide any significant or clinically relevant benefit in terms of BoP and PPD reductions and complete disease resolution, over the use of submarginal instrumentation alone. Baseline PPD < 4 mm, presence of buccal KM and supramucosal restoration margin may play a role in the complete resolution of PM.
引用
收藏
页码:1267 / 1277
页数:11
相关论文
共 50 条
  • [31] One-year clinical outcomes following non-surgical treatment of peri-implant mucositis with adjunctive diode laser application
    Mariani, Giulia M.
    Ercoli, Elena
    Guzzi, Nicoletta
    Bongiovanni, Loretta
    Bianco, Laura
    Romano, Federica
    Aimetti, Mario
    MINERVA STOMATOLOGICA, 2020, 69 (05): : 269 - 277
  • [32] Erythritol air polishing in the surgical treatment of peri-implantitis: A randomized controlled trial
    Hentenaar, Diederik F. M.
    De Waal, Yvonne C. M.
    Stewart, Roy E.
    Van Winkelhoff, Arie Jan
    Meijer, Henny J. A.
    Raghoebar, Gerry M.
    CLINICAL ORAL IMPLANTS RESEARCH, 2022, 33 (02) : 184 - 196
  • [33] Anti-infective treatment of peri-implant mucositis: a randomised controlled clinical trial
    Heitz-Mayfield, Lisa J. A.
    Salvi, Giovanni E.
    Botticelli, Daniele
    Mombelli, Andrea
    Faddy, Malcolm
    Lang, Niklaus P.
    CLINICAL ORAL IMPLANTS RESEARCH, 2011, 22 (03) : 237 - 241
  • [34] Effect of Adjunctive Use of Probiotics in the Treatment of Peri-Implant Mucositis: A Systematic Review and Meta-Analysis
    Villafuerte, Kelly Rocio Vargas
    Martinez, Cristhiam de Jesus Hernandez
    Santos, Karina Oliveira
    APPLIED SCIENCES-BASEL, 2023, 13 (19):
  • [35] Domiciliary Use of Chlorhexidine vs. Postbiotic Gels in Patients with Peri-Implant Mucositis: A Split-Mouth Randomized Clinical Trial
    Butera, Andrea
    Pascadopoli, Maurizio
    Pellegrini, Matteo
    Gallo, Simone
    Zampetti, Paolo
    Cuggia, Giada
    Scribante, Andrea
    APPLIED SCIENCES-BASEL, 2022, 12 (06):
  • [36] Clinical effects of the adjunctive use of a 0.03% chlorhexidine and 0.05% cetylpyridinium chloride mouth rinse in the management of peri-implant diseases: A randomized clinical trial
    Pulcini, Alberto
    Bollain, Juan
    Sanz-Sanchez, Ignacio
    Figuero, Elena
    Alonso, Bettina
    Sanz, Mariano
    Herrera, David
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2019, 46 (03) : 342 - 353
  • [37] Evaluation of the efficacy of inter-dental brush and dental floss for peri-implant mucositis: A crossover randomized clinical trial
    Bevilacqua, Lorenzo
    Lorenzon, Maria Giulia
    Bjedov, Marianna
    Costantinides, Fulvia
    Angerame, Daniele
    Maglione, Michele
    INTERNATIONAL JOURNAL OF DENTAL HYGIENE, 2024, 22 (03) : 779 - 788
  • [38] Difference of Two Antiseptic Gels for the Treatment of Peri-Implant Mucositis on Plaque Index and Bleeding Score: A Randomized Controlled Clinical Study
    Storelli, Stefano
    Palandrani, Giulia
    Manfredi, Barbara
    Romeo, Eugenio
    De Martis, Dario
    Todaro, Claudia
    Baena, Ruggero
    Lupi, Saturnino Marco
    APPLIED SCIENCES-BASEL, 2023, 13 (03):
  • [39] Efficacy of Er:YAG laser for the peri-implantitis treatment and microbiological changes: a randomized controlled trial
    Chen, Jen-Hao
    Lin, Ying-Chun
    Kung, Jung-Chang
    Yan, Dah-You
    Chen, I-Hui
    Jheng, You-Syun
    Lai, Chern-Hsiung
    Wu, Yi-Min
    Lee, Kun-Tsung
    LASERS IN MEDICAL SCIENCE, 2022, 37 (09) : 3517 - 3525
  • [40] Ozonized Hydrogels vs. 1% Chlorhexidine Gel for the Clinical and Domiciliary Management of Peri-Implant Mucositis: A Randomized Clinical Trial
    Butera, Andrea
    Pascadopoli, Maurizio
    Gallo, Simone
    Martinez, Carlos Perez-Albacete
    de Val, Jose Eduardo Mate Sanchez
    Parisi, Luca
    Gariboldi, Alice
    Scribante, Andrea
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)